IPO Timeline
Broker Results (T-2)
2021-06-16
Some brokers release in afternoon
Grey Market (T-1)
2021-06-17
Afternoon
HKEX Allotment (T-1)
2021-06-17
Evening
Registrar Allotment (T-1)
2021-06-17
Evening
Listing Day (T)
2021-06-18
First day of trading
Company Overview
| Stock Name | 科濟藥業控股有限公司 - B |
|---|---|
| Stock Code | 02171 |
| Company Full Name | 科濟藥業控股有限公司 - B |
| Industry | 醫療保健 |
| Principal Activities | 主要從事生物制藥業務，專注治療血液惡性腫瘤和實體瘤的CAR-T細胞療法。 |
| Listing Date | 2021-06-18 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市徐匯區銀都路388號12幢 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.carsgen.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 32.80 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 49.9% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 1,553,850,800 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 30.0 |
|---|---|
| First Day Open | HK$ 27.05 |
| First Day Change | -8.54% |
| First Day Volume | 54398500.0 |
| First Day Turnover | 1608210000.0 |
Use of Proceeds
| Use of Proceeds | 1、約882.1百萬港元（113.7百萬美元）（或約30%的所得款項凈額）將用于為進一步開發我們的核心候選產品BCMA CAR-T (CT053)提供資金； 2、約911.6百萬港元（117.5百萬美元）（或約31%的所得款項凈額）將用于為我們正在進行及已籌劃的其他管線候選產品的研發活動提供資金； 3、約588.2百萬港元（75.8百萬美元）（或約20%的所得款項凈額）用于培養全面的制造及商業化能力； 4、約147.0百萬港元（37.9百萬美元）（或約10%的所得款項凈額）用于繼續升級CAR-T技術及為早期研發活動提供資金； 5、約264.7百萬港元（34.1百萬美元）（或約9%的所得款項凈額）將用于營運資金及其他一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
高盛（亚洲）有限责任公司 CE ACC536
UBS Securities Hong Kong Limited CE BIN466
Overall Coordinators (4)
高盛（亚洲）有限责任公司 CE ACC536
UBS Securities Hong Kong Limited CE BIN466
中信里昂证券有限公司 CE AAB893
Credit Suisse (Hong Kong) Limited CE AAO017
Joint Bookrunners (4)
高盛（亚洲）有限责任公司 CE ACC536
UBS Securities Hong Kong Limited CE BIN466
中信里昂证券有限公司 CE AAB893
Credit Suisse (Hong Kong) Limited CE AAO017
Joint Lead Managers (4)
高盛（亚洲）有限责任公司 CE ACC536
UBS Securities Hong Kong Limited CE BIN466
中信里昂证券有限公司 CE AAB893
Credit Suisse (Hong Kong) Limited CE AAO017
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | CloudAlpha Master Fund | 235,930,400 HKD | — | 7.59% | — | 6 months | 2021-12-18 |
| 2 | Dymon Asia Capital (Singapore) Pte. Ltd. | 67,518,800 HKD | — | 2.17% | — | 6 months | 2021-12-18 |
| 3 | Foresight Orient Global Superior Choice SPC | 202,556,400 HKD | — | 6.52% | — | 6 months | 2021-12-18 |
| 4 | LAV Amber Limited | 337,594,000 HKD | — | 10.86% | — | 6 months | 2021-12-18 |
| 5 | WT Asset Management Limited | 135,037,600 HKD | — | 4.35% | — | 6 months | 2021-12-18 |
| 6 | 常春藤资产管理(香港)有限公司 | 67,518,800 HKD | — | 2.17% | — | 6 months | 2021-12-18 |
| 7 | 广发基金管理有限公司 | 135,037,600 HKD | — | 4.35% | — | 6 months | 2021-12-18 |
| 8 | 南方基金管理股份有限公司 | 67,518,800 HKD | — | 2.17% | — | 6 months | 2021-12-18 |
| 9 | 新华资本管理有限公司 | 303,449,200 HKD | — | 9.76% | — | 6 months | 2021-12-18 |
Directors & Management
| Chairman | 李宗海 |
|---|---|
| Company Secretary | 呂穎一 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 李宗海及關連人士(37.77%);新加坡政府投資有限公司(5.83%) |
|---|
IPO Timeline
